Premium
Clinical outcomes of transarterial chemotherapy and embolization for vaginal cancer
Author(s) -
Bi Yonghua,
Yi Mengfei,
Yu Zepeng,
Han Xinwei,
Ren Jianzhuang
Publication year - 2020
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/jog.14234
Subject(s) - medicine , embolization , chemotherapy , radiation therapy , adenosquamous carcinoma , adenocarcinoma , vaginal cancer , radiology , cancer , leiomyosarcoma , transarterial embolization , surgery , cervical cancer
Aim We report clinical outcomes of transarterial embolization in 19 cases of vaginal cancer. Methods From August 2011 to October 2019, 19 patients with histologically diagnosed vaginal cancer were identified in our department. Transarterial chemotherapy and embolization was performed for all patients. Patient characteristics, treatment plans and the clinical outcomes, were recorded. Results Among 19 identified cases, nine of them are squamous cell carcinoma, five of adenocarcinoma, one of adenosquamous carcinoma, two of vaginal malignant melanoma, one leiomyosarcoma and one of stromal sarcoma. Transarterial chemotherapy and embolization was successfully performed in all patients. No related complication was found after intervention treatment. Besides, eight patients received adjuvant chemotherapy, four received both adjuvant chemotherapy and radiotherapy and seven received no therapies. Four patients were cured and seven were stable during follow‐up. Conclusion Transarterial embolization appears safe and effective for vaginal cancer, with a currently acceptable prognosis.